Lotus Bio-Technology Development Corp. engages in improving healthcare and advancing diagnostics through technology development and market acquisition. The company is headquartered in Costa Mesa, California. The company went IPO on 2013-03-14. The firm delivers a series of at-home diagnostic tests that help form a complete picture of their current overall health including hormone levels, allergies, sensitivities, and any pre-existing conditions or infections. Then, based on those results, and a user's interests, lifestyle and goals, an advisor from The Company works with the individual one on one to help customize a wellness plan that incentivizes them to continue caring for their health and reach new goals. Through the Company's at-home diagnostic testing, customizable wellness plans, and strategic partnerships, the Company provides access to healthcare and improve quality of life for its users.
Follow-Up Questions
Lotus Bio-Technology Development Corp 的 CEO 是誰？
Mr. Zoltan Nagy 是 Lotus Bio-Technology Development Corp 的 President，自 2011 加入公司。
LBTD 股票的價格表現如何？
LBTD 的當前價格為 $0，在上個交易日 decreased 了 0%。
Lotus Bio-Technology Development Corp 的主要業務主題或行業是什麼？
Lotus Bio-Technology Development Corp 屬於 N/A 行業，該板塊是 N/A
